Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SQI Diagnostics Inc V.SQD.H

Alternate Symbol(s):  SQIDF

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by FactFinder1994on May 24, 2023 3:56pm
91 Views
Post# 35462477

So few can connect all of the dots, but when you do....

So few can connect all of the dots, but when you do....

As stated in recent investor presentation, real-time biomarker testing has long been desired to improve decision-making precision during EVLP and the TORdx LUNG assay makes this a clinical reality.
(read that again and understand what it is saying....this is very real and has been sought after for a long time).    

Watch the video link below and recognize all of the infustructure that is already in place and operational.  The LBE trial is now fully enrolled and confirmatory results are pending.  Results will largely mirror that of UHN, which are stellar.    
 
LBE & UHN have well established systems and protocols with all the necessary support in place.
SQI's small but important contribution (TORdx), is a very simple addition that has beed desired for many years.  LBE and UHN have had the vision for many years and TORdx fills the need perfectly.  
If the market for TORdx LUNG is $100M out of the gate, then ask yourself what a 100% of $100M is?  
This is a captive protocol/market where there is no substitute test.  SQI's is the one and only, as UHN and Shaf Keshavjee are the ones to confirm the protocol.  This protocol is followed by participants all over the world and is updated accordingly for best outcomes.

Proven product with support of the premier LUNG key opinion leader in the world, where more Lung transplants (UHN) occur than any other facility.

This is a no-brainer for all that are intimate enough with the story, but it remains largely under the radar.  

SQI Management and Directors grasp just how large the market opportunity is from a dollars perspective and the impact on human lives is also very significant.  Health care systems also stand the benefit greatly too.  

With proven technology, captive markets, partnerships with the best of the best in respiratory and LUNG transplant domain, and Directors that have the wherewithal to get it done.....well its a no-brainer for all involved.  Who wouldn't support such a rich return from all perspectives (financially & humanitarian).  Could there be a more significant impact opportunity for the big three Directors of SQI than this one before us?  While the Matthews $25M donation to the under the Gardiner expressway project was very meaningful, SQI is the gift that keeps on giving and will impact lives globally for years and years to come.  This has to be among the key initiatives in their lives, as it not only saves lives, but it will also provide a very healthy financial return for all involved as well.  Very rewarding to make such an impact on human health.  Legacy is another term I think of.  Reputations, integrity, and using the power for greater good.     

So many of the most influential people are involved one way or another in SQI.  Some have suggested that these people leave nothing to chance.  Put yourself in the shoes of any of these individuals, and understand the great pride they must have knowing SQI has essential pieces for optimization of the EVLP CLES transplant process.  Great power and great outcomes for all involved.  

Lung Bioengineering is nearly a decade in and is so heavily invested.  SQI's contribution will assist them greatly, along with all of the participating centers.  The US Government's recent organ transplant system announcement also bodes well for SQI & LBE.  

If you have not already digested the most recent investor deck, it is worth reading.  Second link below.
Here are some of the key/exciting themes....
Predicting outcomes, leaders in science of lung health, life-saving decisions, non-invasive, disruptive, unmet needs, addressable markets exceeding $2B, Triage, early warning systems, speed to result, Novel tests, Superior KOL's and world-leading partners, precision, cost-effective, convert standard of care,.....all from a company that so few have ever even had an opportunity to hear about.  

There are so few that really understand the opportunity that has been created here.  Its like a best kept secret, but that should change.  If anyone in an influentail position stood up and pieced it all together the following/support would be exuberant.  Its time to have this story be known.  Massive impact to human health and also for all stakeholders.       

https://www.lungbioengineering.com/clinicaltrial-03641677/#elementor-action%3Aaction%3Dlightbox%26settings%3DeyJ0eXBlIjoidmlkZW8iLCJ2aWRlb1R5cGUiOiJ5b3V0dWJlIiwidXJsIjoiaHR0cHM6XC9cL3d3dy55b3V0dWJlLmNvbVwvZW1iZWRcL3VjdGNqNjdOZWhBP2ZlYXR1cmU9b2VtYmVkIn0%3D

SQI-Diagnostics-Inc-Corporate-Information-MAY23-www.pdf


<< Previous
Bullboard Posts
Next >>